company background image
H02 logo

Haw Par SGX:H02 Stock Report

Last Price

S$11.17

Market Cap

S$2.5b

7D

-0.09%

1Y

14.6%

Updated

23 Nov, 2024

Data

Company Financials

Haw Par Corporation Limited

SGX:H02 Stock Report

Market Cap: S$2.5b

H02 Stock Overview

Manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. More details

H02 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Rewards

Price-To-Earnings ratio (10.5x) is below the SG market (11.5x)

Earnings grew by 33.8% over the past year

Risk Analysis

Dividend of 3.58% is not well covered by free cash flows


Haw Par Corporation Limited Competitors

Hyphens Pharma International

Catalist:1J5

S$91.1m

Harmony Biosciences Holdings

NasdaqGM:HRMY

US$1.9b

Hunan Jiudian Pharmaceutical

SZSE:300705

CN¥11.5b

Eris Lifesciences

NSEI:ERIS

₹187.0b

Price History & Performance

Summary of all time highs, changes and price drops for Haw Par
Historical stock prices
Current Share PriceS$11.17
52 Week HighS$11.35
52 Week LowS$9.44
Beta0.37
11 Month Change2.48%
3 Month Change10.48%
1 Year Change14.56%
33 Year Change-7.07%
5 Year Change-16.70%
Change since IPO425.90%

Recent News & Updates

Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

Sep 08
Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Apr 25
Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Recent updates

Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

Sep 08
Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Apr 25
Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Haw Par Corporation Limited's (SGX:H02) CEO For Now

Apr 16
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Haw Par Corporation Limited's (SGX:H02) CEO For Now

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Apr 02
Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Haw Par (SGX:H02) Is Increasing Its Dividend To SGD0.20

Aug 14
Haw Par (SGX:H02) Is Increasing Its Dividend To SGD0.20

Haw Par (SGX:H02) Could Easily Take On More Debt

Jun 17
Haw Par (SGX:H02) Could Easily Take On More Debt

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.15

Apr 04
Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.15

Haw Par (SGX:H02) Has A Rock Solid Balance Sheet

Oct 20
Haw Par (SGX:H02) Has A Rock Solid Balance Sheet

Haw Par (SGX:H02) Will Pay A Dividend Of SGD0.15

Aug 12
Haw Par (SGX:H02) Will Pay A Dividend Of SGD0.15

Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15

Apr 28
Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15

Haw Par (SGX:H02) Is Due To Pay A Dividend Of S$0.15

Apr 06
Haw Par (SGX:H02) Is Due To Pay A Dividend Of S$0.15

Haw Par (SGX:H02) Has Affirmed Its Dividend Of S$0.15

Feb 27
Haw Par (SGX:H02) Has Affirmed Its Dividend Of S$0.15

Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15

Aug 23
Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15

Is Haw Par Corporation Limited (SGX:H02) Popular Amongst Institutions?

Jan 24
Is Haw Par Corporation Limited (SGX:H02) Popular Amongst Institutions?

Should Haw Par Corporation Limited (SGX:H02) Be Part Of Your Dividend Portfolio?

Jan 03
Should Haw Par Corporation Limited (SGX:H02) Be Part Of Your Dividend Portfolio?

Haw Par Corporation Limited (SGX:H02) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Dec 13
Haw Par Corporation Limited (SGX:H02) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Shareholders Of Haw Par (SGX:H02) Must Be Happy With Their 50% Return

Nov 23
Shareholders Of Haw Par (SGX:H02) Must Be Happy With Their 50% Return

Shareholder Returns

H02SG PharmaceuticalsSG Market
7D-0.09%-2.1%0.007%
1Y14.6%4.9%14.5%

Return vs Industry: H02 exceeded the SG Pharmaceuticals industry which returned 4.9% over the past year.

Return vs Market: H02 matched the SG Market which returned 14.5% over the past year.

Price Volatility

Is H02's price volatile compared to industry and market?
H02 volatility
H02 Average Weekly Movement1.7%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement4.5%
10% most volatile stocks in SG Market14.7%
10% least volatile stocks in SG Market2.2%

Stable Share Price: H02 has not had significant price volatility in the past 3 months compared to the SG market.

Volatility Over Time: H02's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969n/aEe Lim Weewww.hawpar.com

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities.

Haw Par Corporation Limited Fundamentals Summary

How do Haw Par's earnings and revenue compare to its market cap?
H02 fundamental statistics
Market capS$2.47b
Earnings (TTM)S$234.43m
Revenue (TTM)S$239.06m

10.5x

P/E Ratio

10.3x

P/S Ratio

Is H02 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
H02 income statement (TTM)
RevenueS$239.06m
Cost of RevenueS$102.66m
Gross ProfitS$136.40m
Other Expenses-S$98.03m
EarningsS$234.43m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.06
Gross Margin57.06%
Net Profit Margin98.06%
Debt/Equity Ratio1.0%

How did H02 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

38%

Payout Ratio